NEOVIDEO : Impact of Monitoring Motor Activity by Video Analysis on the Sleep of Very Preterm Infants
1 other identifier
interventional
74
1 country
2
Brief Summary
Very premature birth and the necessary hospitalization expose to a risk of morbidity and mortality which impacts the neurodevelopmental prognosis. Sleep and behavior monitoring have not been developed in the neonatal units. This has to be improved since it is known from clinical and animal studies that the quality, organization and quantity of sleep in very preterm infants impact neurological development and brain plasticity. The collection system provide neonatal care nurse with access to motion curves (evaluated by signal processing of live video) and real-time infrared video (also available in low-light conditions). This new non-invasive technology allows an evaluation of the activity cycles of the newborn by the caregivers which until now was only accessible occasionally by short recordings of actigraphy or polysomnography. The investigators wish to demonstrate that this can contribute to an organization of care that respects the sleep patterns of the newborn, which they know to condition the neurodevelopmental prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
November 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2022
CompletedApril 16, 2024
April 1, 2024
1.5 years
November 5, 2020
April 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Quantification of the percentage of time spent in sleep
Quantification of the percentage of time spent in sleep (stage 1 + 2 of the neurobehavioral classification of Prechtl in 5 stages compared to the total duration of the analyzable tracing) by a supervised expert, viewing the blinded sequences of the condition tested (with and without access caregivers to video and movement curves).
for 8 days
Secondary Outcomes (11)
Quantification of the ratio of time spent in calm sleep / time spent in restless sleep .
for 8 days
- Quantification of the percentage of time spent in the 5 stages of Prechtl / total analyzable tracing time.
for 8 days
- Quantification of sleep fragmentation and the different types of transitions: number and duration of awakening periods
for 8 days
- Quantification of sleep fragmentation and the different types of transitions: number and duration of movement periods (periods defined by successions of movements spaced less than 5 seconds apart)
for 8 days
- Quantification of sleep fragmentation and the different types of transitions: classification of all transitions between stages
for 8 days
- +6 more secondary outcomes
Study Arms (2)
Acess to Videos and Movement curves
EXPERIMENTALwith caregivers' access to videos and movement curves (4 days)
No Acess to Video and Movement curves
NO INTERVENTIONwithout caregivers' access to videos and movement (4 days)
Interventions
intervention of caregivers with access to videos and motion curves of the premature infant
Eligibility Criteria
You may qualify if:
- New born :
- hospitalized in neonatology,
- at least one of whose legal representatives has given free, informed and written consent,
- term of birth \<32 WA, postnatal age\> 15 days and post-conceptual age between \[30-38\] WA,
- affiliated to a social security scheme
- Caregivers:
- having at least 1 year of practical experience in neonatology,
- having been trained in the clinical basics of evaluating newborn sleep,
- having given their consent to participate.
You may not qualify if:
- New born :
- sedative or curare treatment (opiates, benzodiazepines, curare, barbiturates) in the last 24 hours,
- chromosomal abnormalities identified
- Planned discharge date incompatible with the completion of the entire study
- No criteria for caregivers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Rennes Hôpital Sud
Rennes, Brittany Region, 35000, France
Pôle Femme Mère Enfant
Brest, 29200, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Céline CITTE, pediatric nurse
University Hospital of Rennes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2020
First Posted
November 10, 2020
Study Start
November 17, 2020
Primary Completion
May 17, 2022
Study Completion
September 22, 2022
Last Updated
April 16, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share